Anti-Diabetic Activity of Polysaccharides from Auricularia cornea var. Li.

Auricularia cornea var. Li. polysaccharide (ACP) has many important biological activities and has potential application value in food engineering, pharmaceutical science, and health care. The results were as follows: the extraction rate of ACP was 28.18% +/- 1.41% and the purity of ACP was 86.92% +/- 2.80%. ACP contains mannitol 32.41%, glucuronic acid 6.96%, rhamnose 0.32%, glucose 42.35%, galactose 0.77%, xylose 16.83%, and fucose 0.36%, without galacturonic acid and arabinose. In addition, the results of an animal test of diabetes mellitus II (DM II) with ACP showed that the total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and fasting blood glucose and water in the serum of mice with ACP were significantly lower than those in the model group; the serum SOD, hepatic glycogen, and insulin of mice added with ACP were significantly higher than those in the model group. More importantly, ACP had no significant adverse effects on organ index and liver and kidney tissue morphology in mice. These results suggest that ACP can be used as a potential functional food component for the prevention or treatment of diabetes.

Automated summary

Auricularia cornea var. Li. polysaccharide (ACP) has potential application value in food engineering, pharmaceutical science, and health care due to its important biological activities. The extraction rate and purity of ACP are relatively high, and it has significant effects on reducing blood lipids and glucose, as well as enhancing antioxidant capacity. Moreover, ACP does not have significant adverse effects on organs and tissues.